Zydus Lifesciences Adjusts Evaluation Amid Strong Management Efficiency and Growth Metrics
Zydus Lifesciences has recently experienced a change in evaluation, reflecting its strong management efficiency with a 19.00% return on equity and a low debt-to-equity ratio of 0.09. The company has shown consistent operational performance, achieving positive results for seven consecutive quarters and a 22.23% annual growth in operating profit.
Zydus Lifesciences, a prominent player in the Pharmaceuticals & Drugs industry, has recently undergone an adjustment in evaluation. This revision reflects a complex interplay of various financial metrics and market dynamics. The company has demonstrated strong management efficiency, highlighted by a return on equity (ROE) of 19.00%, indicating effective utilization of shareholder funds.Additionally, Zydus Lifesciences maintains a low debt-to-equity ratio of 0.09 times, suggesting a conservative approach to leverage. The firm has also reported healthy long-term growth, with operating profit increasing at an annual rate of 22.23%. Notably, the company has achieved positive results for seven consecutive quarters, showcasing consistent operational performance.
Despite these strengths, the stock is currently positioned within a bearish technical range, which has influenced its recent evaluation. The stock's price-to-book value stands at 4.1, reflecting a premium compared to its peers' historical valuations. Over the past year, while the stock has generated a return of -1.52%, profits have risen by 33.2%, with a PEG ratio of 0.6 indicating a favorable growth outlook relative to its valuation.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
